← SynDRA
DIMETHYLCURCUMIN
SynDRA canonical compound SYN0004558 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | AR |
| Mechanism of action | androgen receptor enhancer |
All known targets
Mechanisms of action (all sources)
- AR DEGRADER
- androgen receptor enhancer
- AR ENHANCER
- AR INHIBITOR
Cross-references
Synonyms
- ASCJ-9
- CHC-004
- GO-Y-025
- Go-Y025
- ASC-JMX1
- ASCJ-9 (systemic), AndroScience
- ASCJ-9 (topical), AndroScience
- Androgen antagonist (alopecia/acne), AndroScience
- Androgen receptor degradation enhancers (oral, spinal bulbar muscular atrophy), AndroScience
- ASC J9
- (1E,4Z,6E)-1,7-bis(3,4-dimethoxyphenyl)-5-hydroxyhepta-1,4,6-trien-3-one
- 1,7-Bis-(3,4-dimethoxyphenyl)-5-hydroxy-hepta-1,4,6-trien-3-one
- 1,7-Bis-(3,4-dimethoxy-phenyl)- 5-hydroxy-hepta-1,4,6-trien-3-one
- (1E,4E,6E)-1,7-Bis(3,4-dimethoxyphenyl)-5-hydroxyhepta-1,4,6-trien-3-one
- Dimethylcurcumin (ASC-J9)
- 1,7-Bis(3,4-dimethoxyphenyl)-5-hydroxyhepta-1,4,6-trien-3-one
- SCHEMBL3487103
- DTXSID10200352
- EX-A927
- AMY15692
- 3454AH
- MFCD12912341
- MFCD22123809
- NSC734923
- RSC004738
- s6630
- AKOS015891371
- AKOS025311328
- ZINC100007120
- CS-0533
- DB06133
- LS40141
- NSC-734923
- SB18767
- 1,4,6-Heptatrien-3-one, 1,7-bis(3,4-dimethoxyphenyl)-5-hydroxy-, (1E,4Z,6E)--
- 1,4,6-Heptatrien-3-one, 1,7-bis(3,4-dimethoxyphenyl)-5-hydroxy-, (Z,E,E)-
- AC-31058
- DS-14720
- HY-15194
Look up DIMETHYLCURCUMIN in the interactive SynDRA portal →